{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:51:24Z","timestamp":1780984284607,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bioorg.2025.108511","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T19:04:16Z","timestamp":1745607856000},"page":"108511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Dialkyloxyphenyl hybrids as PDE4B inhibitors: Design, synthesis, in vitro\/in vivo anti-inflammatory activity and in silico insights"],"prefix":"10.1016","volume":"161","author":[{"given":"Aya M.","family":"Almatary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.H.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed R.","family":"Elnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"Aboutaleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda A.-A.","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bioorg.2025.108511_bb0005","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.coph.2011.10.003","article-title":"Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment","volume":"11","author":"Levy","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108511_bb0010","series-title":"PDE4 cAMP-Specific Phosphodiesterases, Progress in Nucleic Acid Research and Molecular Biology","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0079-6603(01)69049-4","author":"Houslay","year":"2001"},{"key":"10.1016\/j.bioorg.2025.108511_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115195","article-title":"Advances in the development of phosphodiesterase-4 inhibitors","volume":"250","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108511_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2023.123039","article-title":"Structural insights into the lead identification of sub-type selective PDE4B inhibitors from plant bioactive molecule analogues","volume":"390","author":"Sharma","year":"2023","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioorg.2025.108511_bb0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejmech.2019.04.020","article-title":"InCl3 mediated heteroarylation of indoles and their derivatization via CH activation strategy: discovery of 2-(1H-indol-3-yl)-quinoxaline derivatives as a new class of PDE4B selective inhibitors for arthritis and\/or multiple sclerosis","volume":"174","author":"Sunke","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2025.108511_bb0030","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1016\/j.bmc.2009.03.061","article-title":"Identification of PDE4B over 4D subtype-selective inhibitors revealing an unprecedented binding mode","volume":"17","author":"Kranz","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108511_bb0035","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.bmcl.2010.02.044","article-title":"Identification of pyridazino[4,5-b]indolizines as selective PDE4B inhibitors","volume":"20","author":"Donnell","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108511_bb0040","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1016\/j.bmcl.2009.04.121","article-title":"Discovery of selective PDE4B inhibitors","volume":"19","author":"Naganuma","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"19","key":"10.1016\/j.bioorg.2025.108511_bb0045","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1016\/j.bmcl.2018.04.068","article-title":"Tetrahydroquinoline and tetrahydroisoquinoline derivatives as potential selective PDE4B inhibitors","volume":"28","author":"Li","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108511_bb0050","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ejmech.2017.12.069","article-title":"Design, synthesis, and biological evaluation of novel catecholopyrimidine based PDE4 inhibitor for the treatment of atopic dermatitis","volume":"145","author":"Purushothaman","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108511_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00485","article-title":"A novel Catecholopyrimidine based small molecule PDE4B inhibitor suppresses inflammatory cytokines in atopic mice","volume":"9","author":"Purushothaman","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"16","key":"10.1016\/j.bioorg.2025.108511_bb0060","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1016\/j.bmcl.2014.06.002","article-title":"Discovery of triazines as selective PDE4B versus PDE4D inhibitors","volume":"24","author":"Hagen","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108511_bb0065","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.bmcl.2013.12.076","article-title":"Identification of the 5,5-dioxo-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives as highly selective PDE4B inhibitors","volume":"24","author":"Goto","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"13","key":"10.1016\/j.bioorg.2025.108511_bb0070","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1039\/c3ob27424a","article-title":"Novel N-indolylmethyl substituted olanzapine derivatives: their design, synthesis and evaluation as PDE4B inhibitors","volume":"11","author":"Gorja","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2025.108511_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01582","article-title":"Identification of a selective PDE4B inhibitor from Bryophyllum pinnatum by target fishing study and in vitro evaluation of quercetin 3-O-\u03b1-L-Arabinopyranosyl-(1\u21922)-O-\u03b1-L-Rhamnopyranoside","volume":"10","author":"Louren\u00e7o","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108511_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107689","article-title":"Targeting next-generation PDE4 inhibitors in search of potential management of rheumatoid arthritis and psoriasis","volume":"151","author":"Bhuktar","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108511_bb0085","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jaad.2017.01.052","article-title":"Long-term safety and tolerability of apremilast in patients with psoriasis: pooled safety analysis for \u2265156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)","volume":"77","author":"Crowley","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108511_bb0090","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0165-5728(00)00265-4","article-title":"The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents","volume":"108","author":"Dinter","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bioorg.2025.108511_bb0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/COPD.S89849","article-title":"Roflumilast: a review of its use in the treatment of COPD","volume":"11","author":"Wedzicha","year":"2016","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.bioorg.2025.108511_bb0100","series-title":"Pharmacology and Therapeutics of Asthma and COPD","first-page":"63","article-title":"Xanthines and phosphodiesterase inhibitors","author":"Spina","year":"2017"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108511_bb0105","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0022-3565(24)37221-0","article-title":"SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitroanti-inflammatory actions","volume":"284","author":"Barnette","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"20","key":"10.1016\/j.bioorg.2025.108511_bb0110","doi-asserted-by":"crossref","first-page":"8538","DOI":"10.1021\/acs.jmedchem.7b01050","article-title":"The discovery of a novel phosphodiesterase (PDE) 4B-preferring radioligand for positron emission tomography (PET) imaging","volume":"60","author":"Zhang","year":"2017","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108511_bb0115","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.3390\/ijms22083832","article-title":"Challenges on cyclic nucleotide phosphodiesterases imaging with positron emission tomography: novel radioligands and (pre-) clinical insights since 2016","volume":"22","author":"Schr\u00f6der","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108511_bb0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.molcel.2004.07.005","article-title":"A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases","volume":"15","author":"Zhang","year":"2004","journal-title":"Mol. Cell"},{"issue":"5594","key":"10.1016\/j.bioorg.2025.108511_bb0125","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1074683","article-title":"Targeting of cyclic AMP degradation to \u03b22-adrenergic receptors by \u03b2-arrestins","volume":"298","author":"Perry","year":"2002","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108511_bb0130","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.str.2004.10.004","article-title":"Structural basis for the activity of drugs that inhibit phosphodiesterases","volume":"12","author":"Card","year":"2004","journal-title":"Structure"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108511_bb0135","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.str.2004.10.004","article-title":"Structural basis for the activity of drugs that inhibit Phosphodiesterases","volume":"12","author":"Card","year":"2004","journal-title":"Structure"},{"issue":"22","key":"10.1016\/j.bioorg.2025.108511_bb0140","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S1359-6446(05)03622-6","article-title":"Keynote review: phosphodiesterase-4 as a therapeutic target","volume":"10","author":"Houslay","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2025.108511_bb0145","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1054-3589(08)60128-3","article-title":"The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: intracellular targeting, regulation, and selective inhibition by compounds exerting anti-inflammatory and antidepressant actions","volume":"44","author":"Houslay","year":"1998","journal-title":"Adv. Pharmacol."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108511_bb0150","doi-asserted-by":"crossref","first-page":"E1414","DOI":"10.1073\/pnas.1419906112","article-title":"Engineered stabilization and structural analysis of the autoinhibited conformation of PDE4","volume":"112","author":"Cedervall","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3\u20134","key":"10.1016\/j.bioorg.2025.108511_bb0155","doi-asserted-by":"crossref","first-page":"1700403","DOI":"10.1002\/ardp.201700403","article-title":"Design, synthesis, and molecular modeling of heterocyclic bioisostere as potent PDE4 inhibitors","volume":"351","author":"Almatary","year":"2018","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2025.108511_bb0160","series-title":"Method for Preparing 3-Cyclopentyloxy-4-Methoxybenzaldehyde","author":"Wilk","year":"2006"},{"issue":"04","key":"10.1016\/j.bioorg.2025.108511_bb0165","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-1979-28650","article-title":"A one-step synthesis of 4-oxo-2-thioxopyrimidine derivatives by the ternary condensation of ethyl cyanoacetate, aldehydes, and thiourea","volume":"1979","author":"Kambe","year":"1979","journal-title":"Synthesis"},{"key":"10.1016\/j.bioorg.2025.108511_bb0170","first-page":"357","article-title":"Synthesis, antitumor activity and molecular docking study of novel benzofuran-2-yl pyrazole pyrimidine derivatives, Acta pol pharm","volume":"68","author":"El-Zahar","year":"2011","journal-title":"Drug Res"},{"key":"10.1016\/j.bioorg.2025.108511_bb0175","doi-asserted-by":"crossref","DOI":"10.1080\/00397911.2017.1332223","article-title":"Design, Synthesis of New Pyrimidine Derivatives as Anticancer and Antimicrobial Agents","author":"Mohamed","year":"2017","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2025.108511_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108295","article-title":"Triazole-linked thiazolidinedione-Benzothiazole hybrids: design and biological evaluation as AChE inhibitors","author":"Almatary","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108511_bb0185","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0026-895X(25)10530-0","article-title":"Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase","volume":"48","author":"Seldon","year":"1995","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108511_bb0190","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0022-3565(24)29287-9","article-title":"Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-\u03baB and nuclear factor of activated T cells activation","volume":"299","author":"Jimenez","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108511_bb0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pupt.2004.09.027","article-title":"Phosphodiesterase 4-selective inhibition: novel therapy for the inflammation of COPD","volume":"18","author":"Jeffery","year":"2005","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"16","key":"10.1016\/j.bioorg.2025.108511_bb0200","doi-asserted-by":"crossref","first-page":"9442","DOI":"10.3390\/ijms23169442","article-title":"Augmented therapeutic potential of ec-synthetic retinoids in caco-2 cancer cells using an in vitro approach","volume":"23","author":"Abdelaal","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2025.108511_bb0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2025.108511_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113004","article-title":"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment","volume":"211","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108511_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071098","article-title":"Efficient, long term production of monocyte-derived macrophages from human pluripotent stem cells under partly-defined and fully-defined conditions","volume":"8","author":"Wilgenburg","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108511_bb0220","first-page":"813","article-title":"Evaluation of the significance of elevated levels of systemic and localized tumor necrosis factor in different animal models of inflammation","volume":"124","author":"Sekut","year":"1994","journal-title":"J. Lab. Clin. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108511_bb0225","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pupt.2004.01.003","article-title":"The role of neutrophils in LPS-induced changes in pulmonary function in conscious rats","volume":"17","author":"Spond","year":"2004","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2025.108511_bb0230","series-title":"Gaussian 16, Gaussian, Inc. Wallingford, CT","author":"Frisch","year":"2016"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108511_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/chir.23673","article-title":"Impact of helical elongation of symmetric oxa [n] helicenes on their structural, photophysical, and chiroptical characteristics","volume":"36","author":"Salem","year":"2024","journal-title":"Chirality"},{"issue":"24","key":"10.1016\/j.bioorg.2025.108511_bb0240","doi-asserted-by":"crossref","first-page":"9068","DOI":"10.3390\/molecules27249068","article-title":"Two-step synthesis, structure, and optical features of a double hetero [7] helicene","volume":"27","author":"Salem","year":"2022","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108511_bb0245","doi-asserted-by":"crossref","first-page":"112015","DOI":"10.5796\/electrochemistry.23-67092","article-title":"Data-driven electrochemical one-pot synthesis of double hetero [7] dehydrohelicene","volume":"91","author":"Salem","year":"2023","journal-title":"Electrochemistry"},{"key":"10.1016\/j.bioorg.2025.108511_bb0250","doi-asserted-by":"crossref","first-page":"133266","DOI":"10.1016\/j.tet.2023.133266","article-title":"Two-pot synthesis of unsymmetrical hetero [7] helicenes with intriguing optical properties","volume":"133","author":"Salem","year":"2023","journal-title":"Tetrahedron"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108511_bb0255","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1063\/1.473796","article-title":"Calculation of ionization energies, electron affinities, electronegativities, and hardnesses using density functional methods","volume":"106","author":"De Proft","year":"1997","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bioorg.2025.108511_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134887","article-title":"Ni (II), Pd (II) and Pt (II) complexes with SNO-group thiosemicarbazone and DMSO: synthesis, characterization, DFT, molecular docking and cytotoxicity","volume":"1278","author":"Arafath","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108511_bb0265","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.1021\/acsomega.3c06274","article-title":"Designing, characterization, DFT, biological effectiveness, and molecular docking analysis of novel Fe (III), co (II), and cu (II) complexes based on 4-hydroxy-2 H-pyrano [3, 2-c] quinoline-2, 5 (6 H)-dione","volume":"9","author":"Khalaf","year":"2024","journal-title":"ACS Omega"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825003918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825003918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:27:25Z","timestamp":1762223245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825003918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":53,"alternative-id":["S0045206825003918"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108511","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dialkyloxyphenyl hybrids as PDE4B inhibitors: Design, synthesis, in vitro\/in vivo anti-inflammatory activity and in silico insights","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108511"}}